Neuland Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 18.50 Cr
- Paid Up Capital ₹ 12.43 Cr
- Company Age 31 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 153.40 Cr
- Revenue Growth 33.34%
- Profit Growth -82.17%
- Ebitda -64.26%
- Net Worth -6.54%
- Total Assets 0.52%
About Neuland Health Sciences
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100TG1993PTC015554
-
Company No.
015554
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Mar 1993
-
Date of AGM
28 Dec 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Neuland Health Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Namita Afzulpurkar
|
Company Secretary | 25-Sep-2015 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sumeet Nagar
|
Additional Director | 23-Jun-2017 | Current |
|
Saharsh Davuluri
|
Director | 14-Oct-1999 | Current |
|
Ramamohan Rao
|
Director | 16-Apr-2012 | Current |
|
Sucheth Davuluri
|
Director | 07-Mar-1997 | Current |
Financial Performance of Neuland Health Sciences.
Neuland Health Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 33.34% increase. The company also saw a substantial fall in profitability, with a 82.17% decrease in profit. The company's net worth dipped by a decrease of 6.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuland Health Sciences?
In 2017, Neuland Health Sciences had a promoter holding of 64.11% and a public holding of 35.89%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Neuland Laboratories Ltd.Ramamohan Rao, Sucheth Davuluri and 1 more are mutual person
-
Ypo South Asia ChapterSucheth Davuluri is a mutual person
-
Malabar Investment Advisors Private LimitedSumeet Nagar is a mutual person
-
Malabar Aif Managers Private Limited
Sumeet Nagar is a mutual person
-
Visage Lines Personal Care Private LimitedSumeet Nagar is a mutual person
-
Safari Industries (India) LimitedSumeet Nagar is a mutual person
Charges (Loans)
₹0
₹153.40 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 150.90 Cr
- Canbank Factors Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2005 | State Bank Of India | ₹150.90 Cr | Satisfied |
| 29 Jan 2001 | Canbank Factors Limited | ₹2.50 Cr | Satisfied |
How Many Employees Work at Neuland Health Sciences?
Unlock and access historical data on people associated with Neuland Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuland Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
